Michael Voss Appointed VP of Spectranetics’ VI Business
Spectranetics Corporation has appointed Michael J. Voss as vice president and general manager of Vascular Intervention (VI). Mr. Voss has over 15 years of experience in the medical device business with a broad sales and marketing background. Prior to joining Spectranetics, he was the Global Vice President of Marketing for Bard Access Systems at CR Bard, where he was responsible for planning, brand building, sales promotions and pricing for a division with annual revenues in excess of $500 million. Prior to CR Bard, he was at Cordis, a Johnson & Johnson company, in several positions including division sales manager and director of marketing for coronary stents. Mr. Voss started his medical device career at Boston Scientific Corporation where he served in a variety of roles including global marketing manager, product manager, business unit manager, and manufacturing manager. He also served six years in the United States Army, where he earned the rank of Captain. His responsibilities at Spectranetics will include sales, sales training, marketing, and overall strategy development for the VI business, which includes atherectomy devices, support catheters and thrombectomy and chronic total occlusion products recently acquired from Kensey Nash Corporation.
LATEST NEWS
- Relativity Networks Raises $4.6M to Scale Next-Gen Optical Fiber Tech
Feb 11, 2025
- With Transformation Plan in Effect, NUBURU Makes Further Changes to Leadership
Feb 11, 2025
- Plastic Optical Fibers Enable Temperature Sensing with High Resolution
Feb 11, 2025
- Salience Labs Closes $30M Funding Round
Feb 10, 2025
- Single-Photon (and Long Range) Lidar Provides Eye-Safe, High-Resolution 3D Imaging
Feb 10, 2025
- Accuron Acquires Trymax Semiconductor: Week in Brief: 02/07/25
Feb 7, 2025
- Accurate Magnetic Field Measurement Method Could Advance Quantum Sensing
Feb 7, 2025
- Superradiance Will Enhance Spatial and Temporal Resolution in Superresolution Imaging
Feb 6, 2025